These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10780798)

  • 1. Immunoblot analysis for laboratory diagnosis of ataxia-telangiectasia: use of Epstein-Barr virus-transformed or phytohemagglutinin-stimulated lymphoblasts for detection of ATM protein.
    Fukao T; Yoshida T; Kaneko H; Song XQ; Tashita H; Teramoto T; Inoue R; Watters D; Lavin M; Kondo N
    J Investig Allergol Clin Immunol; 2000; 10(1):36-40. PubMed ID: 10780798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of BLM (the causative gene for Bloom syndrome) and screening of Bloom syndrome.
    Morimoto W; Kaneko H; Isogai K; Kasahara K; Kondo N
    Int J Mol Med; 2002 Jul; 10(1):95-9. PubMed ID: 12060858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM is upregulated during the mitogenic response in peripheral blood mononuclear cells.
    Fukao T; Kaneko H; Birrell G; Gatei M; Tashita H; Yoshida T; Cross S; Kedar P; Watters D; Khana KK; Misko I; Kondo N; Lavin MF
    Blood; 1999 Sep; 94(6):1998-2006. PubMed ID: 10477729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells.
    Lakin ND; Weber P; Stankovic T; Rottinghaus ST; Taylor AM; Jackson SP
    Oncogene; 1996 Dec; 13(12):2707-16. PubMed ID: 9000145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.
    Cortés ML; Bakkenist CJ; Di Maria MV; Kastan MB; Breakefield XO
    Gene Ther; 2003 Aug; 10(16):1321-7. PubMed ID: 12883528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoassay to measure ataxia-telangiectasia mutated protein in cellular lysates.
    Butch AW; Chun HH; Nahas SA; Gatti RA
    Clin Chem; 2004 Dec; 50(12):2302-8. PubMed ID: 15486025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
    Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms.
    Watters D; Khanna KK; Beamish H; Birrell G; Spring K; Kedar P; Gatei M; Stenzel D; Hobson K; Kozlov S; Zhang N; Farrell A; Ramsay J; Gatti R; Lavin M
    Oncogene; 1997 Apr; 14(16):1911-21. PubMed ID: 9150358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM mutations in cancer families.
    Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
    Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder effects for ATM gene mutations in Italian Ataxia Telangiectasia families.
    Chessa L; Piane M; Magliozzi M; Torrente I; Savio C; Lulli P; De Luca A; Dallapiccola B
    Ann Hum Genet; 2009 Sep; 73(Pt 5):532-9. PubMed ID: 19691550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
    Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
    Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
    Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
    Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ataxia telangiectasia].
    Hosoi H; Sawada T
    Nihon Rinsho; 2000 Jul; 58(7):1505-10. PubMed ID: 10921332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
    J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma.
    Bose S; Yap LF; Fung M; Starzcynski J; Saleh A; Morgan S; Dawson C; Chukwuma MB; Maina E; Buettner M; Wei W; Arrand J; Lim PV; Young LS; Teo SH; Stankovic T; Woodman CB; Murray PG
    J Pathol; 2009 Feb; 217(3):345-52. PubMed ID: 19142888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
    Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.